A Strategy for Management of Electroconvulsive Therapy Patients During the COVID-19 Pandemic
- PMID: 32826544
- PMCID: PMC7299101
- DOI: 10.1097/YCT.0000000000000702
A Strategy for Management of Electroconvulsive Therapy Patients During the COVID-19 Pandemic
Conflict of interest statement
Conflict of Interest Statement:
There are no potential conflicts of interests to disclose. No funding received from National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI).
Figures
Comment in
-
Editor's Roundup for Issue #3 of 2020: More About Electroconvulsive Therapy and COVID-19.J ECT. 2020 Sep;36(3):147-148. doi: 10.1097/YCT.0000000000000712. J ECT. 2020. PMID: 32732594 No abstract available.
References
-
- Practice Guidance for COVID-19, April 10th, 2020 (APA website). Available at: https://www.psychiatry.org/psychiatrists/covid-19-coronavirus/practice-g... (Accessed 04/10/2020)
-
- Kokkinakis I, Selby K, Favrat B, Genton B, Cornuz J. Covid-19 diagnosis; clinical recommendations and performance of nasopharyngeal swab-PCR. Rev Med Suisse. 2020. Apr 8;16(689):699–701. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
